DR. DIPANJAN CHOWDHURY RECEIVES ADDITIONAL FUNDING FROM A GENEROUS DANA-FARBER DONOR
A donor has gifted $5 million to the Division of Gynecologic Oncology in the Susan F. Smith Center for Women’s Cancers at… View more
NEW TECHNOLOGY BEING DEVELOPED FOR SMARTPHONE DEVICES TO DETECT BRCA1 GENE MUTATION
An exciting new technology is being developed for a smartphone device to detect the BRCA1 gene mutation (which can put an individual… View more
Tina’s Wish Raises $2MM for Early Detection Ovarian Cancer Research at their Annual Benefit
More than 800 Tina’s Wish supporters came together during Ovarian Cancer Awareness Month to raise $2 MILLION for critical scientific research into the early… View more
MAGENTA genetic test alerts woman of her increased risk of developing ovarian cancer
Though there is still no early screening for ovarian cancer, genetic testing is one way to discover if an individual is at… View more
Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant
Through their collaborative efforts, Tina’s Wish Researchers, Daniel Heller, PhD, MSKCC, Ryan Williams, PhD, MSKCC and Douglas Levine, NYU Langone Medical Center… View more
Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer
“Wistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for the… View more